Sugammadex forms very tight complexes in a 1:1 ratio with steroidal neuromuscular blocking agents (rocuronium > vecuronium >> pancuronium). This guest-host complex, which exists in equilibrium ...

A ventilated ICU patient was receiving vecuronium and a potassium chloride infusion. After the patient was extubated, vecuronium was discontinued. An infusion bag containing vecuronium remained in ...

The authors analyzed the existing literature on sugammadex, a drug that encapsulates and inactivates steroidal neuromuscular blocking agents (NMBAs). Published results have demonstrated rapid and ...

Within gene therapy, the Tokyo-based company is focused neuromuscular ... drug for treating vasomotor symptoms caused by menopause. The first-in-class therapy is a small molecule designed to block ...

Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:45 Hrs [IST] Global pharma major Lupin Lim ...

The drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer ...

Racial and ethnic minority patients with severe trauma are less likely to receive airlift services compared with White ...

Co-administration of Daxxify® and aminoglycoside antibiotics, anticholinergic agents or any other agents interfering ... injection is an acetylcholine release inhibitor and neuromuscular blocking ...

Paralytic drugs, or neuromuscular blocking agents (NMBAs), are powerful muscle relaxants used to prevent muscle movement during surgical procedures. They're also used during critical care, such as ...

DNSFilter announced today the release of its 2025 Annual Security Report, showcasing an uptick in malicious requests from 2023 to 2024. At internet scale, threats are relentless, but so is the right ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...